Epigeneron

About:

Epigeneron is a medical company that specializes in research and development, sales, marketing, import, and export of pharmaceutical drugs.

Website: https://epigeneron.com/

Top Investors: UTEC - The University of Tokyo Edge Capital Partners, Tohoku University Venture Partners, Toshiba Corporation

Description:

Implementation of drug discovery and drug discovery support services and sales of drug discovery related information Manufacture, sale and import / export of research reagents, diagnostic agents, and chemical industrial chemicals Manufacture, sale and import / export of research equipment Intellectual property transfer business All business incidental or related to the preceding items

Total Funding Amount:

368M JPY

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Tokyo, Tokyo, Japan

Founded Date:

2015-04-16

Founders:

Hodaka Fujii

Number of Employees:

11-50

Last Funding Date:

2021-03-11

IPO Status:

Private

Industries:

© 2025 bioDAO.ai